BSE filing, BSE: 544804. Summary written from the filing by ALFA Finder's alert engine.
Riyaasat Lifestyle Ltd: key numbers
- Share price
- ₹107.45
- Market cap
- ₹115.5 Cr
- Revenue (annual)
- ₹33.37 Cr
- Net profit (annual)
- ₹5.19 Cr
- P/E (TTM)
- 22.2×Sector 62.0×
- Promoter holding
- 73.39%+0.00% QoQ
- FII holding
- 18.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Riyaasat Lifestyle Ltd
All →Riyaasat Lifestyle Board Meeting Date
Riyaasat Lifestyle Ltd scheduled its board meeting for 30 October 2026 to approve H1 FY27 unaudited results. Trading window remains closed until 3 November 2026.
Riyaasat Lifestyle Annual General Meeting
Riyaasat Lifestyle's shareholders approved the variation in the utilisation of Initial Public Offering proceeds via postal ballot.
Riyaasat Lifestyle Acquisition Worth ₹15.5 Cr
Riyaasat Lifestyle Limited acquired a Mumbai-based immovable property through an e-auction for Rs.15.50 Crore to expand its existing business operations.
- Value
- ₹15.50 Cr
Riyaasat Lifestyle Price Movement Clarification
Riyaasat Lifestyle clarified to the exchange that there is no undisclosed price-sensitive information. The company attributed recent share price movements to market forces.
Riyaasat Lifestyle Annual General Meeting
Riyaasat Lifestyle Limited held its 5th Annual General Meeting on September 29, 2026. Members considered the adoption of audited financial statements and director re-appointments.
Riyaasat Lifestyle Other Announcement
Riyaasat Lifestyle Ltd notified BSE of its CIN change from U18100 to L18100 following its July 1, 2026 listing. The update reflects the MCA status change from Unlisted to Listed.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.